Srinagar: As the world keeps witnessing a rise in novel coronavirus cases every day, Russia, in order to deal with the crisis, is preparing to start a mass vaccination campaign against the deadly virus from October, international media reported.
“The vaccination will be free of charge, and doctors and teachers would be the first to be vaccinated,” a Turkey-based news gatherer Anadolu Agency quoted Mikhail Murashko, Minister of Health of the Russian Federation, as having said.
Murashko, according to the report, said that people will be immunised with the first Russian vaccine developed by the Gamaleya National Research Centre, which is currently in process of getting the state registration, aid.
However, clinical trials of the vaccine will continue along with its production and use in order to improve it as more details emerge.
The first Russian vaccine is based on adenovirus. The report said another vaccine developed by the country’s Defence Ministry is expected to get the same “conditional registration” in September and its production is likely to be launched in October.
Besides this, two more vaccines in the country are being examined by experts for approval of clinical trials.
In India, a week after the All India Institute of Medical Sciences (AIIMS) gave its approval for conducting the human clinical trial of the COVID vaccine, a 30-year-old man was given the first dose of under trial vaccine Covaxin, on July 25.
A total of 12 volunteers were called for a number of pre-tests that include blood and nasopharyngeal testing for the deadly coronavirus.
On July 22, United States President Donald Trump said that his administration is willing to work with anybody, including China if they are the first to produce a successful COVID vaccine.
“We are willing to work with anybody that’s going to get us a good result,” a report by a Delhi based news agency ANI quoted Trump saying while replying to a question that whether he would be ready to work with China if it were first to develop a vaccine.
Free Press Kashmir is now on Telegram. Click here to Join.